AGL Stock — agilon health Inc.

agilon health Inc. (AGL)

Updated October 16, 2026.

AGL is a Stock. Total return is -89.0% over the past 5.5 years, 186.5 points behind SPY at 97.5%.

Agilon Health provides healthcare services for seniors through a network of primary care physicians across the United States, operating on a subscription-like per-member per-month model that manages patients' total healthcare needs. The company does not currently distribute dividends. This business appeals primarily to investors seeking healthcare sector exposure rather than income generation.

AGL performance versus SPY

Price and return data through 2026-10-16.

Total return is -89.0% over the past 5.5 years, 186.5 points behind SPY at 97.5%. Over the past year its total return — price change plus distributions reinvested — is 252.7%. Its deepest 1-year drawdown was 69.0%.

AGL key facts

Asset type

Stock

Asset class

Equity

Inception date

04/15/2021

Distribution frequency

None

Last close

$85.12 (as of 2026-10-16)

Market cap

$1,429,267,795

Average volume

123144.0

Beta

2.995

Payout ratio

0.0%

Forward P/E

178.5714

EPS

$-15.41

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

AGL risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 69.0%.

Who may consider AGL — and who may not

It is a weaker fit for investors who need monthly cash flow (AGL does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on AGL

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions